J&J Innovation taps Texas for its latest biotech startup incubator

Johnson & Johnson ($JNJ) is taking its network of biopharma incubators to Texas in an expansion of its Janssen Labs initiative. To be located at Houston's Texas Medical Center, the incubator hopes to foster as many as 50 local biotech startups. Report

Suggested Articles

Amid Amgen's pricing war with Sanofi and Regeneron's Praluent, PCSK9 cholesterol fighter Repatha has shown a clinical benefit for HIV patients.

A month after the FDA approved it, Esperion's Nexletol showed it can lower cholesterol regardless of statin and ezitimibe treatment.

AstraZeneca's Farxiga can help prevent worsening or death in heart failure patients regardless of other therapies received, according to new data.